Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease.

Immunologic Research
Valerie I BrownStephan A Grupp

Abstract

While the outcome for pediatric patients with lymphoproliferative disorders (LPD) or lymphoid malignancies, such as acute lymphoblastic leukemia (ALL), has improved dramatically, patients often suffer from therapeutic sequelae. Additionally, despite intensified treatment, the prognosis remains dismal for patients with refractory or relapsed disease. Thus, novel biologically targeted treatment approaches are needed. These targets can be identified by understanding how a loss of lymphocyte homeostasis can result in LPD or ALL. Herein, we review potential molecular and cellular therapeutic strategies that (i) target key signaling networks (e.g., PI3K/AKT/mTOR, JAK/STAT, Notch1, and SRC kinase family-containing pathways) which regulate lymphocyte growth, survival, and function; (ii) block the interaction of ALL cells with stromal cells or lymphoid growth factors secreted by the bone marrow microenvironment; or (iii) stimulate innate and adaptive immune responses.

References

Aug 1, 1992·The Journal of Clinical Investigation·M C SnellerW Strober
Sep 18, 1992·Cell·C L SawyersO N Witte
Mar 15, 1990·Nature·N HeisterkampJ Groffen
Jun 18, 1981·The New England Journal of Medicine·P L WeidenUNKNOWN Seattle Marrow Transplant Team
Jul 19, 1994·Proceedings of the National Academy of Sciences of the United States of America·A R GottschalkJ Quintáns
Mar 10, 1995·Science·S Nagata, P Golstein
Oct 18, 1995·Journal of the National Cancer Institute·P J Goodfellow, S A Wells
Jan 1, 1995·Cancer·R W MillerB Novakovic
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·A B RaitanoC L Sawyers
Jul 1, 1997·Klinische Pädiatrie·G BaerschJ Vormoor
Mar 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R ConsoliniD Campana
Jul 17, 1998·The Journal of Clinical Investigation·P YotndaP Langlade-Demoyen
Aug 8, 1998·British Journal of Haematology·J M Chessells
Mar 26, 1999·American Journal of Human Genetics·C E JacksonJ M Puck
Apr 3, 1999·Annals of Internal Medicine·S E StrausW Strober
Jun 24, 1999·Cytokine & Growth Factor Reviews·R HofmeisterS K Durum
Feb 5, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·C WeiI Goldschneider
Feb 5, 2000·Experimental Hematology·T TaguchiJ Fujimoto
Aug 10, 2000·Immunological Reviews·F E BertrandT W LeBien
Sep 7, 2000·The Journal of Experimental Medicine·J E SimsR J Paxton
Dec 29, 2000·Pediatric Clinics of North America·J J BleesingT A Fleisher
Nov 14, 2001·The Journal of Biological Chemistry·O Jameel ShahLeonard S Jefferson

❮ Previous
Next ❯

Citations

May 1, 2012·Current Neurology and Neuroscience Reports·David Neal Franz, Brian D Weiss
Jan 28, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Andrea LapucciSergio Capaccioli
Oct 15, 2009·Hematology/oncology Clinics of North America·Farhad Ravandi, Partow Kebriaei
Dec 21, 2012·Pediatric Blood & Cancer·Stephan A GruppUNKNOWN COG Stem Cell Transplant Scientific Committee
Nov 7, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Bi-Hong ZhangChun Chen
Feb 22, 2012·Clinical Medicine Insights. Oncology·Lydia Lee, Adele K Fielding
Aug 1, 2012·Paediatric Drugs·David BarrettDavid T Teachey

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Trends in Molecular Medicine
Gary G Chiang, Robert T Abraham
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Scott A Armstrong, A Thomas Look
© 2022 Meta ULC. All rights reserved